Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Amgen, Third Point LLC biopharmaceuticals news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Third Point LLC, New York, N.Y. Business: Biopharmaceuticals Activist investor Third Point outlined a plan for increasing Amgen's valuation by more than 80% in the next …

    Published on 10/27/2014
  • Baxter pharmaceuticals, biosimilars, cancer news

    Baxter International Inc. (NYSE:BAX), Deerfield, Ill. Business: Pharmaceuticals, Biosimilars, Cancer This year, Baxter plans to begin work on a new global innovation and R&D center in Cambridge, Massachusetts, for the …

    Published on 10/27/2014
  • GlaxoSmithKline, Novartis pharmaceuticals news

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals GlaxoSmithKline disclosed in its 3Q14 earnings call that it reshuffled its executive …

    Published on 10/27/2014
  • J&J, Texas Medical Center, Yale School of Medicine pharmaceuticals, other news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. Texas Medical Center, Houston, Texas Yale School of Medicine, New Haven, Conn. Business: Pharmaceuticals, Other Johnson & Johnson plans to open the fourth incubator in …

    Published on 10/27/2014
  • ViaCtye Inc., California Institute for Regenerative Medicine endocrine/metabolic news

    ViaCtye Inc., San Diego, Calif. California Institute for Regenerative Medicine (CIRM), San Francisco, Calif. Business: Endocrine/Metabolic CIRM awarded ViaCyte an additional $16.6 million to support clinical testing of …

    Published on 10/27/2014
  • Viamet cancer, infectious news

    Viamet Pharmaceuticals Inc., Durham, N.C. Business: Cancer, Infectious Viamet said it will spin out its prostate cancer program to existing investors in a newco called Innocrin Pharmaceuticals, led by former Viamet CSO …

    Published on 10/27/2014
  • Amgen, Regeneron, Sanofi endocrine/metabolic news

    Amgen Inc. (NASDAQ:AMGN), Thousand Oaks, Calif. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Business: Endocrine/Metabolic Amgen filed a suit in the U.S.…

    Published on 10/20/2014
  • Aptose Biosciences, Oregon Health & Science University, LLS cancer news

    Aptose Biosciences Inc. (TSX:APS; Pink:APSCF), Toronto, Ontario Oregon Health & Science University, Portland, Ore. The Leukemia & Lymphoma Society, White Plains, N.Y. Business: Cancer Aptose (formerly Lorus Therapeutics…

    Published on 10/20/2014
  • Coronado Biosciences dermatology news

    Coronado Biosciences Inc. (NASDAQ:CNDO), Burlington, Mass. Business: Dermatology Coronado formed Journey Medical Corp., a wholly owned subsidiary to acquire and license dermatology products for commercialization. The …

    Published on 10/20/2014
  • DecImmune Therapeutics, NIH cardiovascular news

    DecImmune Therapeutics Inc., Boston, Mass. National Institutes of Health, Bethesda, Md. Business: Cardiovascular DecImmune said NIH awarded the biotech a Phase IIB Small Business Innovation Research (SBIR) contract for…

    Published on 10/20/2014
  • Emergent BioSolutions, U.S. Department of Health and Human Services, NIH infectious news

    Emergent BioSolutions Inc. (NYSE:EBS), Rockville, Md. U.S. Department of Health and Human Services, Washington, D.C. National Institutes of Health, Bethesda, Md. Business: Infectious NIH's National Institute of Allergy…

    Published on 10/20/2014
  • NeuroSearch neurology news

    NeuroSearch A/S (CSE:NEUR), Ballerup, Denmark Business: Neurology NeuroSearch appealed to the Eastern High Court of Denmark an August ruling from the City Court of Copenhagen ordering the company to pay a fine of DKK5 …

    Published on 10/20/2014
  • Bill & Melinda Gates Foundation, Critical Path Institute infectious news

    Bill & Melinda Gates Foundation, Seattle, Wash. Critical Path Institute, Tucson, Ariz. Business: Infectious The institute received a three-year, multi-million dollar grant renewal from the foundation to support …

    Published on 10/13/2014
  • Bioheart gene/cell therapy news

    Bioheart Inc. (OTCQB:BHRT), Sunrise, Fla. Business: Gene/Cell therapy Last month, Bioheart opened its South African Stem Cell Institute (SASCI) laboratory and clinic in South Africa. At least 12 patients underwent …

    Published on 10/13/2014
  • BioMarin endocrine/metabolic news

    BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Novato, Calif. Business: Endocrine/Metabolic BioMarin said an undisclosed company submitted an ANDA to FDA for a generic version of the biotech's Kuvan sapropterin …

    Published on 10/13/2014
  • Cellerant, U.S. Department of Health and Human Services cancer, other news

    Cellerant Therapeutics Inc., San Carlos, Calif. U.S. Department of Health and Human Services, Washington, D.C. Business: Cancer, Other HHS's Biomedical Advanced Research and Development Authority (BARDA) exercised its …

    Published on 10/13/2014
  • Critical Outcome Technologies cancer news

    Critical Outcome Technologies Inc. (TSX-V:COT; OTCQB:COTQF), London, Ontario Business: Cancer Critical Outcome's board approved a shareholder rights plan to protect shareholders in the event of an unsolicited takeover …

    Published on 10/13/2014
  • Emmes Corp., NIH cancer news

    Emmes Corp., Rockville, Md. National Institutes of Health, Bethesda, Md. Business: Cancer CRO Emmes said clinical investigators from the AIDS Malignancy Consortium (AMC) began a study to investigate strategies to …

    Published on 10/13/2014
  • GenoSpace, NIH bioinformatics news

    GenoSpace LLC, Cambridge, Mass. National Institutes of Health, Bethesda, Md. Business:Bioinformatics GenoSpace said NIH awarded the biotech a Small Business Innovation Research (SBIR) grant for about $137,000 over about…

    Published on 10/13/2014
  • Hospira, Orion, Novartis neurology news

    Hospira Inc. (NYSE:HSP), Lake Forest, Ill. Orion Corp. (HSE:ORNAV; HSE:ORNBV), Espoo, Finland Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Neurology Orion, Hospira and Novartis' Sandoz Inc. and Sandoz …

    Published on 10/13/2014
  • Innovation Economy Corp. other news

    Innovation Economy Corp., Riverside, Calif. Business: Other Innovation Economy (dba ieCrowd) launched a life science business group and appointed Molly Schmid as VP of the group. ieCrowd, a discovery-to-market …

    Published on 10/13/2014
  • Kymab, Regeneron antibodies news

    Kymab Ltd., Cambridge, U.K. Regeneron Pharmaceuticals Inc. (NASDAQ:REGN), Tarrytown, N.Y. Business: Antibodies Kymab said the European Patent Office (EPO) has granted Kymab's request to entirely revoke Regeneron's EP1,…

    Published on 10/13/2014
  • MediciNova, NIH neurology news

    MediciNova Inc. (NASDAQ:MNOV; JASDAQ:4875), San Diego, Calif. National Institutes of Health, Bethesda, Md. Business: Neurology MediciNova said NIH's National Institute on Drug Abuse (NIDA) awarded a grant to continue …

    Published on 10/13/2014
  • Mimetas, National Center for the Replacement, Radboud University Nijmegen Medical Center, University of Applied Sciences and Arts Northwestern Switzerland supply/service news

    Mimetas B.V., Leiden, the Netherlands National Center for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), London, U.K. Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands …

    Published on 10/13/2014
  • Navidea, NIH diagnostic news

    Navidea Biopharmaceuticals Inc. (NYSE-M:NAVB), Dublin, Ohio National Institutes of Health, Bethesda, Md. Business: Diagnostic Navidea said NIH's NCI awarded the biotech a Small Business Innovation Research (SBIR) …

    Published on 10/13/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993